Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

21.93 +0.04 (+0.16%)
Streaming Delayed Price Updated: 2:22 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CeriBell, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Global AI Infrastructure Shift Ignites Biotech Growth Phase
From USA News Group
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures 
From Ceribell
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q3 2025 Earnings Call Transcript ↗
CeriBell (CBLL) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Reports Third Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
From Ceribell
Via GlobeNewswire
News headline image
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companies 
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q2 Revenue Jumps 38% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Ceribell Reports Second Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) Technology 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Reports First Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
From Ceribell
Via GlobeNewswire
News headline image
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 ↗
According to the company, its current U.S. inventory is expected to cover demand through the third quarter of 2025. 
Via Stocktwits
Topics Government World Trade
News headline image
Top stock movements in today's session. ↗
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It ↗
The stock has shown solid performance despite market volatility, making it likely that insiders will sell to cash in on gains. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Discover the top movers in Monday's pre-market session. ↗
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.